Clinical Effect of Combined Therapy with Triple Nebulization and Montelukast Sodium Orally Dissolving Films in the Treatment of Pediatric Asthmatic Bronchopneumonia

Fengping Du

Show Less

¹ Chifeng Maternity and Child Health Care Hospital, Chifeng 024000, Inner Mongolia Autonomous Region, China,

JCNR 2025 , 9(6), 273–278; https://doi.org/10.26689/jcnr.v9i6.11087

© 2025 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Abstract

Objective: To evaluate the efficacy of montelukast sodium orally dissolving films combined with triple nebulization in the treatment of pediatric asthmatic bronchopneumonia. Methods: A total of 60 pediatric patients with asthmatic bronchopneumonia who visited the hospital from December 2021 to December 2024 were selected as samples and randomly divided into two groups. Group A received combined therapy with montelukast sodium orally dissolving films, while Group B received triple nebulization therapy. The time to symptom relief, serum inflammatory factors, and adverse reactions were compared between the two groups. Results: The duration of asthma, cough, and wheezing, as well as the length of hospital stay, were shorter in Group A than in Group B (P < 0.05). The levels of C-reactive protein (CRP), white blood cell count (WBC), and serum amyloid A (SAA) were lower in Group A than in Group B (P < 0.05). The incidence of adverse reactions was lower in Group A than in Group B (P < 0.05). Conclusion: The combination therapy of montelukast sodium orally dissolving films and triple nebulization for pediatric asthmatic bronchopneumonia can effectively inhibit inflammation, shorten the duration of symptoms, and is safe and efficient.

References

Deng J, Huang J, 2023, Clinical Study of Montelukast Sodium Combined With Budesonide in the Treatment of Bronchial Asthma in Children. Chinese Journal of Clinical Pharmacology, 39(14): 1983–1986.

Mao Q, Gu X, 2023, Zhu Futang and Zhu Futang Practical Pediatrics. China Health Talent, 2023(7): 56–58.

Sha N, Wang Y, 2021, Effect of Montelukast Combined With Fluticasone Furoate on Children With Bronchial Asthma. Northwest Pharmaceutical Journal, 36(2): 283–287.

Liao S, 2024, Clinical Effect of Montelukast Sodium Combined With Budesonide and Terbutaline in the Treatment of Cough Variant Asthma in Children. Journal of Clinical Rational Drug Use, 17(7): 98–100.

Lin M, 2024, Clinical Effect of Montelukast Sodium Combined With Budesonide Inhalation in the Treatment of Bronchial Asthma in Children and Its Impact on Lung Function. Journal of Clinical Rational Drug Use, 17(13): 81–84.

Ge W, 2025, Effects of Vitamin AD Combined With Montelukast Sodium and Budesonide on Children With Bronchial Asthma. Chinese and Foreign Medical Research, 23(7): 57–60.

Zhang H, Yan T, Qian J, 2022, Clinical Effect and Respiratory Mechanics Observation of Terbutaline and Montelukast Sodium Combination Therapy for Bronchial Asthma. Medical Journal of the Chinese People’s Liberation Army, 34(6): 96–99.

Chen Y, Chen H, Xiao Y, et al., 2020, Effect of Terbutaline Combined With Montelukast Sodium in the Treatment of Bronchial Asthma Patients and Its Impact on Inflammatory Factors and Respiratory Mechanics. Journal of Difficult Diseases, 19(1): 26–29+35.

Qiao Y, 2020, Observation on the Effect of Pediatric Qingre Kechi Oral Liquid Combined With Nebulized Acetylcysteine Solution in the Treatment of Bronchial Pneumonia in Children. Chinese Remedies & Clinics, 20(18): 3072–3074.

Wang Q, 2023, Terbutaline Combined With Montelukast Sodium in the Treatment of Bronchial Pneumonia With Acute Asthma Attack in Children. Journal of Shanxi Vocational College of Health, 33(3): 18–20.

Mao X, 2021, Effect of Montelukast Combined With Terbutaline Inhalation on Lung Function Indexes of Children With Bronchial Asthma. Drug Evaluation, 18(18): 1138–1140.

Pan C, 2022, Clinical Effect of Budesonide Combined With Montelukast in the Treatment of Bronchial Asthma in Children and Its Impact on T Lymphocyte Subsets and Cytokine Levels. Journal of Clinical Rational Drug Use, 15(29): 136–138.

Ruan R, Chen M, Liu X, et al., 2019, Therapeutic Effect of Recombinant Human Interferon α2b Combined With Montelukast Sodium in the Treatment of Pediatric Bronchial Pneumonia With Elevated IgE. Journal of Guangxi Medical University, 36(1): 90–93.

Yan J, 2024, Effect of Recombinant Human Interferon α2b Combined With Montelukast Sodium in the Treatment of Bronchial Pneumonia in Children and Its Impact on Inflammatory Response. Journal of Aerospace Medicine, 35(10): 1198–1200.

Duan W, Wu H, Liu Y, et al., 2024, Efficacy of Jiedu Qingfei Mixture Combined With Montelukast Sodium in the Treatment of Bronchial Asthma Complicated With Mycoplasma Pneumoniae Infection. Chinese Journal of Nosocomiology, 34(17): 2631–2636.

Previous article in this issue

Next article in this issue